MedTrace Logo

Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood

NCT00146055 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2012-08-09

No results posted yet for this study

Summary

The purpose of this study is to determine whether a less-intensive preparative therapy followed by an allogeneic peripheral stem cell transplantation will provide an effective treatment for your disease and whether it will be associated with fewer side effects.

Conditions

  • Myeloma, Plasma-Cell
  • Lymphoma, Malignant
  • Myeloproliferative Disorders
  • Myelodysplastic Syndromes
  • Waldenstrom's Macroglobulinemia

Interventions

PROCEDURE

Reduced intensity conditioning with allogeneic transplant

Sponsors & Collaborators

  • University of Michigan Rogel Cancer Center

    lead OTHER

Principal Investigators

  • John E. Levine, MS MD · The Univeristy of Michigan

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-03-31
Primary Completion
2004-11-30
Completion
2007-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00146055 on ClinicalTrials.gov